Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gardner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Lancet. Rheumatology|January 26, 2024
Rationale for CD40 pathway blockade in autoimmune rheumatic disordersValentina Pucino, David H Gardner, Benjamin A Fisher
Frontiers in Immunology|September 28, 2018
Tertiary Lymphoid Structures: Autoimmunity Goes LocalElena Pipi, Saba Nayar, David H Gardner, et al.
Frontiers in Immunology|November 24, 2016
Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic InflammationFrancesca Barone, David H Gardner, Saba Nayar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2015
1,25(OH)2D3 Promotes the Efficacy of CD28 Costimulation Blockade by AbataceptDavid H Gardner, Louisa E Jeffery, Blagoje Soskic, et al.
Frontiers in Immunology|January 25, 2021
CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg HomeostasisBlagoje Soskic, Louisa E Jeffery, Alan Kennedy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2016
Bimodal Expansion of the Lymphatic Vessels Is Regulated by the Sequential Expression of IL-7 and Lymphotoxin α1β2 in Newly Formed Tertiary Lymphoid StructuresSaba Nayar, Joana Campos, Ming May Chung, et al.
JCI Insight|December 8, 2022
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndromeXavier Mariette, Francesca Barone, Chiara Baldini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathologySaba Nayar, Joana Campos, Charlotte G Smith, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndromeSaba Nayar, Joana Campos, Charlotte G Smith, et al.
Communications Biology|May 4, 2022
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interactionSaba Nayar, Elena Pontarini, Joana Campos, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Lancet. Rheumatology|January 26, 2024
Rationale for CD40 pathway blockade in autoimmune rheumatic disordersValentina Pucino, David H Gardner, Benjamin A Fisher
Frontiers in Immunology|September 28, 2018
Tertiary Lymphoid Structures: Autoimmunity Goes LocalElena Pipi, Saba Nayar, David H Gardner, et al.
Frontiers in Immunology|November 24, 2016
Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic InflammationFrancesca Barone, David H Gardner, Saba Nayar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2015
1,25(OH)2D3 Promotes the Efficacy of CD28 Costimulation Blockade by AbataceptDavid H Gardner, Louisa E Jeffery, Blagoje Soskic, et al.
Frontiers in Immunology|January 25, 2021
CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg HomeostasisBlagoje Soskic, Louisa E Jeffery, Alan Kennedy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2016
Bimodal Expansion of the Lymphatic Vessels Is Regulated by the Sequential Expression of IL-7 and Lymphotoxin α1β2 in Newly Formed Tertiary Lymphoid StructuresSaba Nayar, Joana Campos, Ming May Chung, et al.
JCI Insight|December 8, 2022
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndromeXavier Mariette, Francesca Barone, Chiara Baldini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathologySaba Nayar, Joana Campos, Charlotte G Smith, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndromeSaba Nayar, Joana Campos, Charlotte G Smith, et al.
Communications Biology|May 4, 2022
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interactionSaba Nayar, Elena Pontarini, Joana Campos, et al.
Pageof 2